Deutsche Bank raised its price target on Bausch Health Companies (NYSE: BHC) to $30.00 (from $25.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Bausch Health Companies (BHC) PT Raised to $26 at RBC CapitalAugust 8, 2018 8:12 AM Bausch Health Companies (BHC) Reports Q2 Revenues of $2.125B; Boosts FY18 Adj. EBITDA Guidance, Offers FY18 Revenue OutlookAugust 7, 2018 7:23 AM Form 8-K Bausch Health Companies For: Aug 07August 7, 2018 7:10 AM Bausch Health Companies Inc. Announces Second-Quarter 2018 ResultsAugust 7, 2018 7:00 AM